Adeka Corporation
Stock Price Chart
2026/06/05 UpdatedPrice Trend
2026/06/05 UpdatedPrice & Trading Details
2026/06/05 UpdatedPRICE
TRADING
Analyst Recommendations 5 analysts
Updated 2026/06/05Earnings Calendar
Updated 2026/06/05Shareholder Composition
Updated 2026/06/05Major Holders
Updated 2026/06/05| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Vanguard International Stock Index-Total Intl Stock Indx
|
1.4M | +1.03% | |
|
Tweedy Browne Global Value Fund
|
892.0K | 0.00% | |
|
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
|
809.0K | +1.81% | |
|
iShares Core MSCI EAFE ETF
|
621.8K | 0.00% | |
|
DFA Japanese Small Company Series
|
494.5K | 0.00% | |
|
DFA International Core Equity Portfolio
|
402.6K | -1.23% |
Dividend History
Updated 2026/06/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥60 | -42.3% |
| 2025 | ¥104 | +6.1% |
| 2024 | ¥98 | +30.7% |
| 2023 | ¥75 | -2.6% |
| 2022 | ¥77 | - |
Financial Performance
2026/06/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥361,234M | ¥403,343M | ¥399,770M | ¥407,145M |
| Gross Profit | ¥95,212M | ¥98,218M | ¥104,691M | ¥114,865M |
| Operating Income | ¥34,032M | ¥32,370M | ¥35,429M | ¥41,010M |
| Pretax Income | ¥37,769M | ¥31,662M | ¥39,405M | ¥42,359M |
| Net Income | ¥23,687M | ¥16,778M | ¥22,977M | ¥25,019M |
| EPS | ¥229.65 | ¥163.30 | ¥224.87 | ¥245.55 |
| Operating Margin | 9.42% | 8.03% | 8.86% | 10.07% |
| Balance Sheet | ||||
| Total Assets | ¥475,304M | ¥500,068M | ¥543,057M | ¥543,118M |
| Total Equity | ¥249,968M | ¥260,949M | ¥285,142M | ¥296,690M |
| Total Liabilities | ¥225,336M | ¥239,119M | ¥257,915M | ¥246,428M |
| Cash | ¥84,249M | ¥81,119M | ¥98,429M | ¥110,117M |
| Interest-bearing Debt | ¥56,057M | ¥56,853M | ¥76,035M | ¥64,037M |
| Equity Ratio | 52.59% | 52.18% | 52.51% | 54.63% |
| D/E Ratio | 0.22 | 0.22 | 0.27 | 0.22 |
| Cash Flow | ||||
| Operating CF | ¥21,072M | ¥17,253M | ¥41,954M | ¥46,235M |
| Investing CF | -¥11,330M | -¥19,520M | -¥23,069M | -¥12,553M |
| Financing CF | -¥11,804M | -¥2,618M | -¥4,559M | -¥22,288M |
| Free CF | ¥7,500M | -¥603M | ¥20,203M | ¥30,008M |
| Efficiency | ||||
| ROE | 9.48% | 6.43% | 8.06% | 8.43% |
| ROA | 4.98% | 3.36% | 4.23% | 4.61% |
Latest IR Information
-
Notice of Completion of Share Buyback | June 2026
Takeda Pharmaceutical Company Limited announced that it completed the purchase of 395,000 shares of treasury stock (total amount of 1,614,366,000 yen) from August 2025 to May 2026, bringing the total acquired shares to 4,823,900 shares (total amount of 179,999,366,600 yen).
Read more -
[Adexa] Corporate Officer Changes and Management Structure Reinforcement | May 2026
Adexa, Inc. will hold a shareholder meeting on June 19, 2026, where it plans to change its representative director and establish a new management structure. Yoshiteru Kobayashi is scheduled to assume the position of representative director, succeeding Haruhiko Tomiyasu. This...
Read more -
Notice Regarding Dividend of Surplus (Increase in Dividend)
The Company has decided on the total dividend amount of 5,903 million yen with effective date of June 22, 2026, and has increased the dividend per share to 60 yen. This is an increase of 8 yen from the previous...
Read more -
Fiscal Year 2026 Consolidated Financial Results Supplementary Data
This is a supplementary data of consolidated financial results for the fiscal year ending March 2026, with net sales reaching ¥416.5 billion (up 2.3% YoY) and operating profit of ¥41.6 billion (up 1.5% YoY). Segment-wise, Life Science and Environment Materials...
Read more -
[Adeka] Financial Results for 2026 | Sales of ¥416.5 billion, Net Income of ¥27.8 billion
For the fiscal year ending March 2026, consolidated sales reached ¥416.5 billion (up 2.3% YoY), net income was ¥27.8 billion (up 11.4%), setting a record high. Segment-wise, Chemical Products, Food, and Life Sciences achieved revenue and profit growth. The outlook...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥4,648
Rating Score: 1.83 (Based on 5 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Adeka Corporation engages in chemicals, food products, and life science businesses. The company offers polymer additives, such as antioxidants, UV absorbers/hindered amine light stabilizers, nucleating agents/clarifiers, metal deactivators/additives for filled polymers, flame retardants, epoxy type stabilizers/lubricants/processability improvers/water dispersion type stabilizers; plasticizers/PVC stabilizers; and photo/thermal curing materials, initiators, polymerizable materials, resist materials, thermal paper materials, semiconductor materials, and circuit materials. Its chemical products also include water borne, epoxy, low chlorine epoxy, and urethane resins; surface specialties, such as general-purpose and functional surfactants, functional cosmetic ingredients, lubricant additives, and base materials for lubricants; propylene glycol, peroxygen chemicals, metal soaps, and inorganic chemicals; and inducing sealing materials, as well as civil engineering and construction materials. The company provides its chemical products to electronics and IT, plastics and rubber, personal care, industrial, liquid crystal display, automotive, and building and construction industries, as well as paints, coatings, and adhesives industries. In addition, it offers food products, such as margarines, shortening products, oils and fats for chocolate, frying oil, whipped cream, mayonnaise, and others. Further, the company engages in the design, construction and construction management of equipment plants, equipment maintenance, logistics, warehousing, vehicle leasing, real estate, insurance agency, etc. The company was formerly known as Asahi Denka Co., Ltd. and changed its name to Adeka Corporation in May 2006. Adeka Corporation was incorporated in 1917 and is headquartered in Tokyo, Japan.